CB 10-252 in the treatment of primary hepatocellular carcinoma.
D000328:Adult; D000368:Aged; D000477:Alkylating Agents / Q000627:therapeutic use*; D001391:Azo Compounds / Q000627:therapeutic use*; D001565:Benzoates / Q000627:therapeutic use; D001853:Bone Marrow / Q000187:drug effects; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
D000477:Alkylating Agents; D001391:Azo Compounds; D001565:Benzoates